Article Versions Notes

Moreno DF, Pereira A, Tovar N, Cibeira MT, Magnano L, Rozman M, López-Guerra M, Colomer D, Martín-Antonio B, Jiménez-Segura R, et al. Defining an Ultra-Low Risk Group in Asymptomatic IgM Monoclonal Gammopathy. Cancers. 2021; 13(9):2055. https://doi.org/10.3390/cancers13092055

Moreno, David F., Arturo Pereira, Natalia Tovar, María Teresa Cibeira, Laura Magnano, María Rozman, Mónica López-Guerra, Dolors Colomer, Beatriz Martín-Antonio, Raquel Jiménez-Segura, and et al. 2021. "Defining an Ultra-Low Risk Group in Asymptomatic IgM Monoclonal Gammopathy" Cancers 13, no. 9: 2055. https://doi.org/10.3390/cancers13092055

Moreno, D. F., Pereira, A., Tovar, N., Cibeira, M. T., Magnano, L., Rozman, M., López-Guerra, M., Colomer, D., Martín-Antonio, B., Jiménez-Segura, R., Isola, I., Rodríguez-Lobato, L. G., Oliver-Caldés, A., Mena, M. P., Rosiñol, L., Bladé, J., & Fernández de Larrea, C. (2021). Defining an Ultra-Low Risk Group in Asymptomatic IgM Monoclonal Gammopathy. Cancers, 13(9), 2055. https://doi.org/10.3390/cancers13092055